NCT00735930 2015-04-02
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
National Cancer Institute (NCI)
National Cancer Institute (NCI)